- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$26.63 BnMarket Estimate, 2026
$28.50 BnMarket Forecast, 2034
$49.04 BnCAGR, 2026–2034
7.02%Executive Summary: Middle East and Africa Beta-Glucan Market
- Market Scope: Regional analysis of the Middle East and Africa beta-glucan sector, detailing natural sources, functional applications, health-modulating categories, and key country profiles.
- Market Valuation: Valued at USD 26.63 million in 2025, reaching USD 28.50 million in 2026, and projected to expand to USD 49.04 million by 2034, growing at a CAGR of 7.02% from 2026 to 2034.
- Primary Growth Drivers: Increasing demand for processed and ready-to-eat functional foods, rising awareness of nutritional values, changing dietary norms alongside higher disposable incomes, and widespread preference for immune-boosting health supplements.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Source | Yeast (held the leading market share in 2025, driven by high nutrient density and powerful immune-modulating properties) | Cereal (anticipated at a high growth rate, fueled by rising demand for oat-derived soluble fibers and cholesterol-lowering dietary products) |
| By Application | Food & Beverages (captured the major market share in 2025, supported by expanding functional food sectors across regional hubs) | Pharmaceuticals (projected to register the fastest CAGR, driven by advanced therapeutic formulations and clinical health supplements) |
| By Category | Soluble Beta-Glucan (market leader in 2025, valued for its blood sugar modulation and cholesterol-blocking heart health benefits) | Insoluble Beta-Glucan (high-growth segment driven by targeted digestive balance and specialized nutritional support applications) |
| By Region / Country | South Africa & Israel (market leaders with established functional food frameworks and active wellness consumer bases) | United Arab Emirates (fastest-growing hub propelled by modern retail expansion, high disposable incomes, and premium nutraceutical adoption) |
Major Market Players & Industry Landscape
Market Structure: Highly competitive landscape characterized by major international ingredient manufacturers and biotechnology firms expanding distribution networks across high-potential emerging MEA urban markets.
Key Companies: Biotec Pharmacon ASA (Biotec BetaGlucans AS), Groupe Soufflet S.A, Tate & Lyle plc, Zilor Inc. (Biorigin), Associated British Foods Plc, Biothera the Immune Health Company, Ceapro Inc, Immuno Medic AS, Koninklijke DSM N.V, and Super Beta Glucan (SBG) Inc.
Middle East and Africa Beta-Glucan Market Size
The Middle East and Africa Beta-Glucan Market size was calculated to be USD 26.63 million in 2025 and is anticipated to be worth USD 49.04 million by 2034 from USD 28.50 million In 2026, growing at a CAGR of 7.02% during the forecast period.
Fungal and Cereal products are being used for a long time for medicinal and cosmetic purposes; albeit, the of Beta-glucan was not found until the 20th century. At first Beta-glucans discovered in lichens, and shortly after that, in barley. Increasing interest in oat Beta-glucan is being taken after their cholesterol lowering phenomenon was reported in 1984. Beta-glucan is a polysaccharide which is abundantly found in natural sources such as mushroom, oats, yeast, etc. The physicochemical features of beta-glucan vary depending on the properties of primary structure, degree of branching, linkage type and molecular weight.
Yeast and medicinal mushroom-derived Beta-glucans have been found to contain nutrient which have ability to modulate the immune system. Beta-glucans are further used in various cosmetic products and nutraceutical, as texturing agents, and as soluble fiber supplements, but can get complex in the process of brewing.
Increasing demand for processed and ready to eat food coupled with rising awareness about the nutritional value of functional food is expected to be the primary driver for Middle East and Africa beta-glucan Market over the given period. Changing dietary norms along with rising disposable incomes is further anticipated to drive market growth. Increasing demand for yeast specialty products is projected to have a positive impact on the Middle East and Africa beta glucan market. More advantages associated with consumption of beta glucan like enhanced immune system is a major driver in its use in health and dietary supplements. Its application as yeast additive in biodiesel blending is further projected to drive the market over the period. Shortage of raw materials such as molasses due to its increase in industrial applications and wine blending is expected to hinder beta glucan market growth up to an extent. Various applications which are currently untapped in cosmetic and medicine sector are expected to create huge opportunities for beta glucan market over the next years.
Segmental Analysis
Middle East and Africa Beta-Glucan Market By Source
- Mushroom
- Yeast
- Seaweed
- Cereal
Middle East and Africa Beta-Glucan Market By Application
- Personal Care
- Food & Beverages
- Animal Feed
- Pharmaceuticals
Middle East and Africa Beta-Glucan Market By Category
- Soluble Beta-Glucan
- Insoluble Beta Glucan
Soluble fiber modulates the blood sugar levels while insoluble fiber is helps in having balanced digestion. Soluble beta-glucan is expected to lead the market in Middle East and Africa during the said forecast period. Soluble fibrous Beta-Glucan which is found in oats, works like an adhesive with cholesterol and blocks it from getting reabsorbed into the blood, and consequently bringing down the risk of heart diseases. The growing food & beverage industry is driving the growth of the functional food ingredients market in South Africa, Egypt and Israel, which as a result is influencing the growth of the regional beta-glucan market.
Key Players in the Market
Major players of the MEA Beta-Glucan Market include Biotec Pharmacon ASA (Biotec BetaGlucans AS), Groupe Soufflet S.A, Tate & Lyle plc, Zilor Inc. (Biorigin), Associated British Foods Plc, Biothera the Immune Health Company, Ceapro Inc, Immuno Medic AS, Koninklijke DSM N.V, and Super Beta Glucan (SBG) Inc